MacDonald H R, Lees R K, Bron C
J Immunol. 1985 Dec;135(6):3944-50.
Three rat monoclonal antibodies (MAb) capable of stimulating interleukin 2 (IL 2) production by a variant subline of EL4 thymoma cells (EL4-6.1) have been produced. The stimulatory capacity of these MAb (designated RL73, RL119, and RL388) was originally found to be dependent on the presence of irradiated peritoneal exudate cells; however, this requirement could be replaced by the cellfree supernatant of the "macrophage-like" cell line P388D1 or by biochemically purified human interleukin 1 (IL 1). A number of other rat MAb directed against cell surface structures did not stimulate IL 1-dependent IL 2 production by EL4-6.1 cells; however, certain MAb directed against Thy-1 as well as the lectin phytohemagglutin did have this capacity. Furthermore, the stimulatory activity of MAb RL73, RL119, and RL388 appeared to be restricted to the EL4-6.1 variant line, because neither the parental EL4 line from which it was derived nor a series of ovalbumin-specific T-T hybrids responded to these MAb. The cell surface antigens recognized by MAb RL73, RL119, and RL388 were present on a wide variety of T cell lines and T-T hybrids, as well as on lines of B cell, macrophage, and fibroblast origin. Interestingly, the MAb reacted with the majority (approximately 85%) of thymocytes but not (or only to a very small extent) with resting T lymphocytes. After stimulation by concanavalin A, however, the three MAb reacted strongly with activated T lymphoblasts. The latter data suggest that MAb RL73, RL119, and RL388 may react with cell surface structures that are normally expressed as a consequence of lymphocyte activation.
已制备出三种能够刺激EL4胸腺瘤细胞变异亚系(EL4-6.1)产生白细胞介素2(IL-2)的大鼠单克隆抗体(MAb)。最初发现这些单克隆抗体(命名为RL73、RL119和RL388)的刺激能力依赖于经辐照的腹膜渗出细胞的存在;然而,这一需求可用“巨噬细胞样”细胞系P388D1的无细胞上清液或经生化纯化的人白细胞介素1(IL-1)替代。许多其他针对细胞表面结构的大鼠单克隆抗体不能刺激EL4-6.1细胞产生依赖IL-1的IL-2;然而,某些针对Thy-1的单克隆抗体以及植物血凝素确实具有这种能力。此外,单克隆抗体RL73、RL119和RL388的刺激活性似乎仅限于EL4-6.1变异系,因为其来源的亲本EL4系以及一系列卵清蛋白特异性T-T杂交细胞对这些单克隆抗体均无反应。单克隆抗体RL73、RL119和RL388识别的细胞表面抗原存在于多种T细胞系和T-T杂交细胞以及B细胞、巨噬细胞和成纤维细胞来源的细胞系上。有趣的是,这些单克隆抗体与大多数(约85%)胸腺细胞发生反应,但与静止T淋巴细胞不发生反应(或仅在非常小的程度上发生反应)。然而,在伴刀豆球蛋白A刺激后,这三种单克隆抗体与活化的T淋巴母细胞强烈反应。后一数据表明,单克隆抗体RL73、RL119和RL388可能与通常因淋巴细胞活化而表达的细胞表面结构发生反应。